SCHEMBL14166237

SCHEMBL14166237

O=C(O)NC(c1ccccc1)c1cccc(OCCCCCCCCC2OCCO2)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44
ACACB O00763 1/20 0.41
CHRM3 P20309 6/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYSLTR2 Q9NS75 3/20 0.40
CYSLTR1 Q9Y271 3/20 0.40
HTR1A P08908 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
HRH3 Q9Y5N1 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17074623 1.00 MEN1 (0.44) MEN1KMT2ATAAR1ACACBCHRM3
SCHEMBL14166245 0.88 HDAC1 (0.40) MEN1KMT2ATAAR1ALDH1A1HRH3
SCHEMBL14166374 0.88 HDAC1 (0.36) MEN1KMT2ATAAR1ACACBKDM4E
SCHEMBL14240838 0.87 MEN1 (0.42) MEN1KMT2ATAAR1ACACBCHRM3
SCHEMBL14166268 0.82 MEN1 (0.38) MEN1KMT2ATAAR1ACACBCHRM3
SCHEMBL14166389 0.82 ALOX5 (0.43) MEN1KMT2AACACBKDM4EALDH1A1
SCHEMBL14706766 0.81 CHRM3 (0.67) CHRM3
SCHEMBL14166097 0.81 SMN1; SMN2 (0.39) MEN1KMT2AACACBKDM4EALDH1A1
SCHEMBL14241081 0.81 CHRM3 (0.53) CHRM3
SCHEMBL14166160 0.80 KMT2A (0.52) MEN1KMT2ATAAR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMA SPA (IT) 2015-09-16 EP disclosed
EP-2718280-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.A. (IT) 2014-04-16 EP disclosed
WO-2012168359-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-13 WO disclosed